Hippocratic AI

Builds patient-facing generative AI voice agents for non-diagnostic clinical tasks — post-discharge follow-up, chronic care check-ins, medication reminders, pre-op prep, appointment scheduling, care gap closure, clinical trial recruitment — sold to health systems, payers, pharma, and medtech. Core asset is Polaris, a patented multi-model "safety constellation" architecture where specialist support models supervise a primary conversational LLM; agents are validated by 7,500+ US-licensed clinicians and explicitly barred from diagnosing or prescribing. Polaris 5.0 (April 2026) is a 5-trillion-parameter constellation on a 700B-parameter core model with contextual ASR, cough detection, drug-safety checks, and clinical escalation (including suicidal-ideation and CPS alerts), benchmarked by the company as outperforming frontier voice-deployable models on clinical tasks at latencies they cannot match. Products span outbound patient calls, an "AI Front Door" replacing call centers/digital front doors, an inpatient "Nurse Co-Pilot" voice assistant, and Polaris Life Sciences for biopharma workflows.

Stated: use safety as the wedge ("do no harm", staged clinician validation) to become the trusted default for patient-facing AI, then scale into an era of "healthcare abundance" where AI clinical capacity costs ~$9/hour. Inferred: land-and-expand from outbound calls into the full patient access layer (AI Front Door) and inpatient workflows (Nurse Co-Pilot); diversify beyond provider budgets into higher-margin pharma/medtech (Grove AI acquisition, Life Sciences division under a dedicated president, BCG and KPMG channel partnerships); use the $3.5B-valuation Series C as M&A currency to consolidate healthcare voice AI; vertically control the model-plus-inference stack (proprietary Polaris 5.0 co-engineered onto DigitalOcean's AI-native cloud with NVIDIA Blackwell Ultra GPUs) to hold a structural cost and latency edge over frontier-model wrappers; and go international early (6 countries, NHS trust, Sheba Medical Center, Japan aging-population narrative) where clinician shortages are most acute.

Safety infrastructure as a regulatory-grade barrier: a patented Polaris constellation architecture, 7,500+ US-licensed clinicians in the validation loop, and a claimed track record of 180M+ patient interactions with ~99.9% correct clinical guidance and zero severe harm events — a data and trust asset competitors cannot quickly replicate. Now reinforced by a vertically tuned inference stack (co-engineered with DigitalOcean and NVIDIA: 2x prefill speedup, ~30% higher per-node throughput, 400ms time-to-first-token at production scale) that lets a healthcare-specific model undercut frontier-model latency and cost, and by deep captive distribution: health systems (UHS, WellSpan, Cincinnati Children's) are both investors and customers, and blue-chip VCs (a16z, General Catalyst, Kleiner, CapitalG, NVIDIA) provide capital and compute advantages.